Kumar Pratyush, Bhargava Seema, Agarwal Pankaj Kumar, Garg Ambuj, Khosla Amit
Department of Family Medicine, Sir Gangaram Hospital, New Delhi, India.
Department of Biochemistry, Sir Gangaram Hospital, New Delhi, India.
J Family Med Prim Care. 2019 May;8(5):1671-1677. doi: 10.4103/jfmpc.jfmpc_83_19.
The rising burden of type 2 diabetes mellitus (T2DM) globally has led to huge morbidity and socioeconomic impact in developing countries. In India, too, it has become a silent epidemic and it is estimated that there are over 60 million diabetics. Although in recent years, a lot of research papers have come up on the management of diabetes, latest treatment modalities may not be affordable to all. So, it becomes imperative to prioritize research on prevention and primary care. Magnesium is an intracellular cation and coenzyme for various reactions of the glycolytic pathway. Hypomagnesemia has been shown to precipitate hyperglycemia and has, therefore, been implicated in insulin resistance and its microvascular complications. Poor glycemic control has been associated with retinopathy. Hence, we evaluated association of serum magnesium with T2DM and diabetic retinopathy.
In a cross-sectional study in North India, 250 consenting adult patients from outpatient department of family medicine of our hospital were recruited. Critically ill patients and those on magnesium supplements were excluded. Clinicolaboratory profile was evaluated. Patients were divided based on serum magnesium level ≤ 1.7 mg/dL (group 1) and > 1.7 mg/dL (group 2). Glycemic control and proportion of diabetic retinopathy were compared between these two groups by using univariate regression analysis.
Out of 250 patients, 110 patients (44%) were found to have hypomagnesemia. Glycemia by fasting blood sugar ( = 0.02), post-Prandial blood sugar ( = 0.04), and HbA( = 0.01) was poorly controlled in hypomagnesemia group. In group 1, 62.7% had non proliferative diabetic retinopathy and 21.8% had proliferative diabetic retinopathy, whereas in group 2, 14.3% had nonproliferative diabetic retinopathy and 8.6% had proliferative diabetic retinopathy ( < 0.001).
Magnesium deficiency is associated with increased risk of diabetic retinopathy and poor glycemic control. Dietary supplementation may be advised to prevent such complications and improve glycemic control.
全球2型糖尿病(T2DM)负担的不断增加,给发展中国家带来了巨大的发病率和社会经济影响。在印度,它也已成为一种无声的流行病,据估计糖尿病患者超过6000万。尽管近年来出现了许多关于糖尿病管理的研究论文,但最新的治疗方式并非所有人都能负担得起。因此,必须优先开展预防和初级保健方面的研究。镁是一种细胞内阳离子,也是糖酵解途径各种反应的辅酶。低镁血症已被证明会引发高血糖,因此与胰岛素抵抗及其微血管并发症有关。血糖控制不佳与视网膜病变有关。因此,我们评估了血清镁与T2DM及糖尿病视网膜病变之间的关联。
在印度北部的一项横断面研究中,招募了我院家庭医学门诊的250名成年患者并获得其同意。重症患者和正在服用镁补充剂的患者被排除。评估临床实验室指标。根据血清镁水平≤1.7mg/dL(第1组)和>1.7mg/dL(第2组)对患者进行分组。通过单变量回归分析比较两组之间的血糖控制情况和糖尿病视网膜病变的比例。
在250名患者中,发现110名患者(44%)患有低镁血症。低镁血症组的空腹血糖(=0.02)、餐后血糖(=0.04)和糖化血红蛋白(=0.01)的血糖控制不佳。在第1组中,62.7%患有非增殖性糖尿病视网膜病变,21.8%患有增殖性糖尿病视网膜病变,而在第2组中,14.3%患有非增殖性糖尿病视网膜病变,8.6%患有增殖性糖尿病视网膜病变(<0.001)。
镁缺乏与糖尿病视网膜病变风险增加和血糖控制不佳有关。建议通过饮食补充来预防此类并发症并改善血糖控制。